Recent research has revealed that targeting B7-H3 can inhibit tumor progression and reverse T cell and NK cell suppression in PTEN/TP53-deficient PCa, providing a novel route for therapeutic intervention.14 The gene discussed is CD276; the disease is posterior cortical atrophy.